Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal CancerRamón Salazar, Rob A.�E.�M. Tollenaar, Peter J.K. Kuppen et al.|Journal of Clinical Oncology|2010Cited by 540
The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor StageWilma E. Mesker, Rob A.�E.�M. Tollenaar, Jan M. C. Junggeburt et al.|Analytical Cellular Pathology|2007Cited by 354
Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesisEsther H. Lips, Hans Morreau, Ronald van Eijk et al.|BMC Cancer|2008Cited by 45
Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinomaKarin van der Tuin, Hans Morreau|European Journal of Endocrinology|2019Cited by 41
Metabolic reprogramming related to whole-chromosome instability in models for Hürthle cell carcinomaRuben D. Addie, Hans Morreau|Scientific Reports|2020Cited by 19